Listed

Twist Bioscience Corp

TWSTNasdaqCIK 1581280HealthcareFiscal year ends Sep 30

Reports and events: 128 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Twist Bioscience Corp, Reports and events
FiledFormWhat it isAccession number
2026-08-1917:24 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-098830
2026-08-1918:15 ET8-K7.01 Regulation FD disclosure0001581280-26-000050
2026-08-0517:27 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-26-091280
2026-08-0316:10 ET10-QQuarterly reportPeriod 2026-06-300001581280-26-000047
2026-08-0307:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001581280-26-000044
2026-05-0416:28 ET10-QQuarterly reportPeriod 2026-03-310001581280-26-000040
2026-05-0407:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001581280-26-000037
2026-02-2616:19 ET10-Q/AQuarterly report, amendedPeriod 2025-12-310001581280-26-000029
2026-02-1707:09 ET8-K3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-015730
2026-02-0617:25 ET8-K5.07 Shareholder vote results0001581280-26-000022
2026-02-0216:15 ET10-QQuarterly reportPeriod 2025-12-310001581280-26-000019
2026-02-0207:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001581280-26-000016
2026-01-1208:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001581280-26-000012
2026-01-0616:13 ETDEF 14AProxy statementPeriod 2026-02-050001581280-26-000006
2025-11-1707:31 ET10-KAnnual reportPeriod 2025-09-300001581280-25-000025
2025-11-1407:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001581280-25-000020
2025-08-0616:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001581280-25-000012
2025-08-0416:24 ET10-QQuarterly reportPeriod 2025-06-300001581280-25-000009
2025-08-0407:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001581280-25-000006
2025-05-0516:05 ET10-QQuarterly reportPeriod 2025-03-310001628280-25-022154
2025-05-0507:27 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-25-044352
2025-02-1117:00 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-25-011543
2025-02-0316:09 ET10-QQuarterly reportPeriod 2024-12-310001628280-25-003461
2025-02-0307:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-25-003387
2025-01-0617:24 ETDEF 14AProxy statementPeriod 2025-01-060001628280-25-000641
2024-11-1816:10 ET10-KAnnual reportPeriod 2024-09-300001628280-24-048262
2024-11-1807:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-24-048173
2024-10-1516:16 ET8-K5.02 Departure or appointment of officers or directors0001104659-24-108591
2024-08-0216:24 ET10-QQuarterly reportPeriod 2024-06-300001628280-24-034434
2024-08-0207:33 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-24-034277
2024-05-0216:13 ET10-QQuarterly reportPeriod 2024-03-310001628280-24-020014
2024-05-0216:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-24-019999
2024-02-0716:05 ET8-K5.07 Shareholder vote results0001104659-24-011607
2024-02-0216:04 ET10-QQuarterly reportPeriod 2023-12-310001628280-24-003051
2024-02-0207:32 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-24-002998
2024-01-0516:02 ETDEF 14AProxy statementPeriod 2024-02-060001628280-24-000650
2024-01-0508:08 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-24-001628
2023-11-2116:03 ET10-KAnnual reportPeriod 2023-09-300001628280-23-039767
2023-11-1707:32 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-23-039394
2023-08-0716:34 ET10-QQuarterly reportPeriod 2023-06-300001628280-23-027803
2023-08-0407:32 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001628280-23-027406
2023-08-0407:25 ET8-K/A2.05 Exit or disposal costs0001104659-23-087548
2023-06-0516:31 ET10-K/AAnnual report, amendedPeriod 2022-09-300001628280-23-020881
2023-05-2308:04 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-23-063421
2023-05-0816:19 ET10-QQuarterly reportPeriod 2023-03-310001628280-23-016426
2023-05-0507:33 ET8-K2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits0001628280-23-015988
2023-03-2806:31 ET8-K5.02 Departure or appointment of officers or directors0001104659-23-037343
2023-02-0816:00 ET8-K5.07 Shareholder vote results0001104659-23-014513
2023-02-0716:12 ET10-QQuarterly reportPeriod 2022-12-310001628280-23-002560
2023-02-0307:32 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-23-002145

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:07 ET. Listed shows no prices and gives no investment advice.